File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Role of Actinomyces in the progression of medication-related osteonecrosis of the jaws in an immunocompromised mouse model with periapical disease

TitleRole of Actinomyces in the progression of medication-related osteonecrosis of the jaws in an immunocompromised mouse model with periapical disease
Authors
KeywordsActinomyces
Animal model
Medication-related osteonecrosis of the jaws
Periapical diseases
Zoledronic acid
Issue Date1-Sep-2024
PublisherElsevier
Citation
Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology, 2024, v. 36, n. 5, p. 735-742 How to Cite?
Abstract

Objectives: This study aimed to investigate the role of Actinomyces on the development of MRONJ in an immunocompromised mouse model with periapical disease. Methods: Thirty ovariectomized C57BL/6 N female mice were treated with zoledronic acid (ZA) and dexamethasone (DX) for 12 weeks. At the eighth week of drug administration, pulpal exposure operation was performed on the lower right first molar in Group B and C, meanwhile Actinomyces inoculation was performed at the pulpal entrance of Group C. Group A received no operation as control. After 4 weeks, loads of total bacteria and Actinomyces in the oral cavity were assessed by real-time polymerase chain reaction (PCR). Mandibles were harvested for micro-computed tomography (CT) and histological analysis. Results: Real-time PCR revealed positive detection of Actinomyces in 30% samples in Group C and negative detection in all samples in Group B and control group. Micro-CT examination demonstrated that in ZA treated mice, pulpal exposure significantly increased periapical bone loss, which was significantly aggravated by Actinomyces inoculation. Histological assessment showed vasodilation, acute exudative changes and pulp necrosis in Group B and C. Conclusions: The present study revealed that inoculation of Actinomyces compromises the bone quality but does not further aggravate bone necrosis significantly.


Persistent Identifierhttp://hdl.handle.net/10722/360812
ISSN
2023 Impact Factor: 0.4
2023 SCImago Journal Rankings: 0.194

 

DC FieldValueLanguage
dc.contributor.authorLi, Jing Wen-
dc.contributor.authorRao, Nian Jing-
dc.contributor.authorHuo, Lei-
dc.contributor.authorHelm, Alexandra-
dc.contributor.authorZheng, Li Wu-
dc.date.accessioned2025-09-16T00:30:39Z-
dc.date.available2025-09-16T00:30:39Z-
dc.date.issued2024-09-01-
dc.identifier.citationJournal of Oral and Maxillofacial Surgery, Medicine, and Pathology, 2024, v. 36, n. 5, p. 735-742-
dc.identifier.issn2212-5558-
dc.identifier.urihttp://hdl.handle.net/10722/360812-
dc.description.abstract<p>Objectives: This study aimed to investigate the role of Actinomyces on the development of MRONJ in an immunocompromised mouse model with periapical disease. Methods: Thirty ovariectomized C57BL/6 N female mice were treated with zoledronic acid (ZA) and dexamethasone (DX) for 12 weeks. At the eighth week of drug administration, pulpal exposure operation was performed on the lower right first molar in Group B and C, meanwhile Actinomyces inoculation was performed at the pulpal entrance of Group C. Group A received no operation as control. After 4 weeks, loads of total bacteria and Actinomyces in the oral cavity were assessed by real-time polymerase chain reaction (PCR). Mandibles were harvested for micro-computed tomography (CT) and histological analysis. Results: Real-time PCR revealed positive detection of Actinomyces in 30% samples in Group C and negative detection in all samples in Group B and control group. Micro-CT examination demonstrated that in ZA treated mice, pulpal exposure significantly increased periapical bone loss, which was significantly aggravated by Actinomyces inoculation. Histological assessment showed vasodilation, acute exudative changes and pulp necrosis in Group B and C. Conclusions: The present study revealed that inoculation of Actinomyces compromises the bone quality but does not further aggravate bone necrosis significantly.</p>-
dc.languageeng-
dc.publisherElsevier-
dc.relation.ispartofJournal of Oral and Maxillofacial Surgery, Medicine, and Pathology-
dc.subjectActinomyces-
dc.subjectAnimal model-
dc.subjectMedication-related osteonecrosis of the jaws-
dc.subjectPeriapical diseases-
dc.subjectZoledronic acid-
dc.titleRole of Actinomyces in the progression of medication-related osteonecrosis of the jaws in an immunocompromised mouse model with periapical disease-
dc.typeArticle-
dc.identifier.doi10.1016/j.ajoms.2024.02.006-
dc.identifier.scopuseid_2-s2.0-85186366793-
dc.identifier.volume36-
dc.identifier.issue5-
dc.identifier.spage735-
dc.identifier.epage742-
dc.identifier.eissn2212-5566-
dc.identifier.issnl2212-5558-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats